NEW YORK, Nov. 24 /PRNewswire/ -- Duane Reade Holdings, Inc. today announced that John K. Henry, Chief Financial Officer, is scheduled to present at the Bank of America Merrill Lynch 2009 Credit Conference. The Company's presentation is scheduled for December 2, 2009 at 7:50 a.m. Eastern Time at the Crowne Plaza Times Square in New York, NY. A webcast will be available on the Investors Information section of the Company's website at http://www.duanereade.com from the start of the live presentation until December 18th, 2009.

About Duane Reade

Founded in 1960, Duane Reade is the largest drugstore chain in New York City. In keeping with company's brand vision of New York Living Made Easy, Duane Reade provides New Yorkers with prescriptions, health products and services, beauty products and services, and convenience items for daily life in the city... everything for "How I Feel", "How I Look", and "What I Need Now". As of October 1, 2009, the Company operates 256 stores.

Except for historical information contained herein, the statements in this release and the accompanying discussion on the earnings conference call are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, this document may contain statements, estimates or projections that constitute "forward-looking" statements as defined under U.S. federal securities laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted or expected results. Those risks include, among other things, the competitive environment in the drug store industry in general and in the New York metropolitan area, the ability to open and operate new stores, the continued efforts by payers and government agencies to reduce prescription reimbursement rates and prescription drug benefits, the strength of the economy in general, the economic conditions in the New York greater metropolitan area, changes in federal and state laws and regulations, including the potential impact of changes in regulations surrounding the importation of pharmaceuticals from foreign countries and changes in laws governing minimum wage requirements, changes in the Company's operating strategy, capital expenditure plans or development plans, the Company's ability to attract, hire and retain qualified pharmacy and other personnel, the Company's significant indebtedness, labor disturbances, the continued impact of, or new occurrences of, terrorist attacks in the New York greater metropolitan area and any actions that may be taken in response, demographic changes, the Company's ability to limit fraud and shrink, the results of the Company's legal proceedings and recalls of pharmaceutical products due to health concerns or other reasons. Those and other risks are more fully described in Duane Reade's reports filed with the SEC from time to time, including its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

Contacts:     Duane Reade Holdings, Inc.
              John Henry
              (212) 273-5746
              SVP - Chief Financial Officer

              Investors: Caren Villarreal
              Press: Diane Zappas
              (212) 850-5600
              Financial Dynamics

SOURCE Duane Reade Holdings, Inc.

RELATED LINKS
http://www.duanereade.com